
|Poll|September 29, 2015
"Up the Price by How Much?"
Author(s)Consultantlive Staff
Turing Pharmaceutical's CEO has backed down on the 4000% price hike for Daraprim, but is the damage done? Take our poll.
Advertisement
You’ve read about Turing Pharmaceuticals’ recent attempt to increase the cost of Daraprim by about 4000%.
Do you think this move is:
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA OKs Subcutaneous Guselkumab Regimen for Ulcerative Colitis: Daily Dose
2
FDA Accepts MannKind sBLA for Inhaled Insulin for Children and Adolescents with Diabetes
3
FDA Approves Updated Indication Statement for Upadacitinib in Inflammatory Bowel Disease Treatment
4
"Shared Decision-Making" for COVID-19 Vaccination Signals "Optional" to Too Many, Says Kelly Moore, MD, MPH
5